EPA ethics officials approve former industry insiders for regulatory positions.
Environmental Protection Agency (EPA) ethics officials have interpreted impartiality guidelines in a manner that has facilitated the involvement of several former industry insiders in pivotal regulatory changes, according to documents obtained through the Freedom of Information Act. These ethics decisions enabled a former agriculture lobbyist to participate in the reinstatement of a pesticide previously banned by federal courts, alongside two ex-executives from the chemical industry who are now influencing the agency’s evaluation of formaldehyde’s risks.
Internal communications reviewed by the Center for Biological Diversity reveal that the EPA’s ethics office assessed Kyle Kunkler’s prior lobbying work for the American Soybean Association as not necessitating his recusal from pesticide regulation matters, particularly concerning dicamba. This pesticide has been a focal point for soybean farmers seeking its reinstatement. Under federal loss-of-impartiality regulations, new government employees typically undergo a one-year “cooling-off period” concerning matters linked to their former employers unless exceptions are granted in writing by the ethics office.
Documentation shows that prior to Kunkler’s appointment as the EPA’s lead on pesticides in June, ethics officials provided him with guidance on recusal strategies and addressed his questions about engaging in pesticide regulations given his previous lobbying role. An internal email exchange indicated that skepticism existed about his involvement with the American Soybean Association’s comments to the EPA on dicamba, yet ethics officials concluded he could still work on related comments from other parties.
On July 23, the EPA announced its intention to reinstate dicamba, with formal re-registration anticipated shortly. The EPA’s ethics office has defended its decisions, emphasizing that previous lobbying activities do not equate to a conflict of interest per federal regulations, asserting that Kunkler can engage in regulatory activities pertaining to topics he previously lobbied for.
Critics, including legal experts, express concern about potential biases in regulatory decisions resulting from the involvement of individuals with significant ties to the industries they now regulate. The ethical implications of Kunkler’s participation in pesticide approvals, coupled with comments on the generic nature of his work, have raised eyebrows regarding impartiality.
Similar scrutiny applies to other EPA officials, such as Nancy Beck and Lynn Dekleva, who previously advocated for loosening chemical regulations. Both obtained ethics office clearance to influence chemical policies, although their prior industry affiliations raise questions about the objectivity of their contributions.
The EPA’s recent revisions to formaldehyde regulation, which align with industry preferences, further underscore concerns over potential regulatory favoritism. These revisions assume the existence of safe exposure thresholds, contrasting with earlier Biden administration positions that considered even minimal exposures potentially dangerous. The implications of these regulatory shifts continue to resonate within environmental advocacy circles, as industry ties among EPA officials provoke debates on the integrity of public health protection.
As the agency navigates complex scientific and ethical landscapes, critics call for greater accountability and transparency in regulatory decision-making, emphasizing the need to safeguard public interests against industry influences.
